Companies
Pelosi’s Latest Trade Moves: Major Nvidia Purchase and Microsoft Sell-Off
House Speaker Nancy Pelosi Makes Strategic Stock Adjustments In a notable financial maneuver, House Speaker Nancy Pelosi has disclosed significant...
Delta Airlines Faces $500 Million in Costs Due to Global Tech Outage
CEO Ed Bastian Discusses Financial Impact and Recovery Efforts Delta Airlines (DAL) is grappling with significant financial repercussions following a...
Turbulent Skies Ahead: Kelly Ortberg Takes Helm at Boeing Amidst Financial Struggles
Boeing Appoints New CEO Following Disappointing Q2 Results and Legal Challenges Boeing (BA) has announced a major leadership change, naming...
AMD Reports Strong Q2 2024 Financial Performance Driven by Record Data Center Revenue
Revenue growth and AI advancements position AMD for a promising second half of the year Advanced Micro Devices (AMD) has...
Starbucks Q3 FY2024 Earnings: Navigating Through Challenges with Strategic Initiatives
Despite Revenue Dip, Strong Membership Growth and Strategic Actions Signal a Resilient Future Starbucks Corporation (SBUX) announced its financial results...
PayPal Raises Full-Year Profit Forecast Amid Resilient Consumer Spending and Cost-Cutting Measures
Despite Challenges, PayPal Leverages Operational Efficiency to Project Strong Growth PayPal (PYPL) has once again raised its forecast for full-year...
Corbus Pharmaceuticals: Pioneering Next-Generation Therapies in Cancer and Obesity
Revolutionary Treatments on the Horizon with CRB-701 and CRB-913 Corbus Pharmaceutical (CRPB), an early-stage clinical biotechnology company, is making significant...
Delta Airlines Seeks Legal Recourse Against CrowdStrike and Microsoft Following Costly Outage
Historic Software Glitch Prompts Potential Lawsuit with Prominent Attorney David Boies at the Helm Delta Airlines (DAL) has taken a...
Apple Unveils Apple Intelligence: A Leap Forward in AI Integration
Apple's New AI Suite Set to Revolutionize User Experience and Drive Upgrades On Monday, Apple released the first version of...
TARS Pharmaceuticals: XDEMVY Eye Drops Set for Strong Performance in 2Q24 Amid Strategic Sales Expansion
Anticipated Growth in XDEMVY Sales, Sales Force Expansion, and Promising Pipeline Signal a Bright Future for TARS Pharmaceuticals As we...
